全文获取类型
| 收费全文 | 946902篇 |
| 免费 | 68459篇 |
| 国内免费 | 1386篇 |
专业分类
| 耳鼻咽喉 | 13121篇 |
| 儿科学 | 24774篇 |
| 妇产科学 | 23925篇 |
| 基础医学 | 135037篇 |
| 口腔科学 | 28692篇 |
| 临床医学 | 81968篇 |
| 内科学 | 186435篇 |
| 皮肤病学 | 19587篇 |
| 神经病学 | 73914篇 |
| 特种医学 | 37632篇 |
| 外国民族医学 | 81篇 |
| 外科学 | 154395篇 |
| 综合类 | 18160篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 271篇 |
| 预防医学 | 62829篇 |
| 眼科学 | 21503篇 |
| 药学 | 73613篇 |
| 3篇 | |
| 中国医学 | 2187篇 |
| 肿瘤学 | 58619篇 |
出版年
| 2018年 | 9240篇 |
| 2017年 | 7226篇 |
| 2016年 | 7994篇 |
| 2015年 | 9129篇 |
| 2014年 | 12399篇 |
| 2013年 | 18014篇 |
| 2012年 | 24888篇 |
| 2011年 | 25878篇 |
| 2010年 | 15229篇 |
| 2009年 | 14726篇 |
| 2008年 | 25228篇 |
| 2007年 | 26448篇 |
| 2006年 | 27279篇 |
| 2005年 | 26153篇 |
| 2004年 | 25186篇 |
| 2003年 | 24281篇 |
| 2002年 | 23779篇 |
| 2001年 | 55234篇 |
| 2000年 | 57091篇 |
| 1999年 | 47336篇 |
| 1998年 | 10948篇 |
| 1997年 | 9650篇 |
| 1996年 | 9700篇 |
| 1995年 | 9042篇 |
| 1994年 | 8375篇 |
| 1993年 | 7723篇 |
| 1992年 | 35788篇 |
| 1991年 | 34184篇 |
| 1990年 | 33018篇 |
| 1989年 | 32160篇 |
| 1988年 | 29259篇 |
| 1987年 | 28510篇 |
| 1986年 | 26540篇 |
| 1985年 | 25373篇 |
| 1984年 | 17993篇 |
| 1983年 | 15294篇 |
| 1982年 | 7894篇 |
| 1981年 | 6871篇 |
| 1979年 | 15968篇 |
| 1978年 | 10714篇 |
| 1977年 | 9161篇 |
| 1976年 | 7985篇 |
| 1975年 | 8788篇 |
| 1974年 | 10628篇 |
| 1973年 | 9999篇 |
| 1972年 | 9501篇 |
| 1971年 | 8965篇 |
| 1970年 | 8557篇 |
| 1969年 | 8026篇 |
| 1968年 | 7297篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
121.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217
122.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
123.
124.
125.
Mhd Wasem Alsabbagh Dana Church Lisa Wenger John Papastergiou Lalitha Raman-Wilms Eric Schneider Nancy Waite 《Research in social & administrative pharmacy》2019,15(2):202-206
Background
One approach to boost influenza vaccination coverage has been to expand immunization authority. In 2012, the province of Ontario gave community pharmacists the authority to administer the influenza vaccine.Objective
This study investigates the perspectives of Ontario pharmacy patrons, who had not recently received this vaccine from a pharmacist, regarding this pharmacist service.Methods
A survey was administered in six Ontario community pharmacies to pharmacy patrons who had not received an influenza vaccination from a pharmacist during the previous year. The instrument included questions about influenza vaccination, and knowledge of and attitudes toward vaccines and pharmacist-administered immunization.Results
A total of 541 pharmacy patrons completed the survey (53.9% response rate). About one-third (30.5%) of respondents were not aware that pharmacists could give the influenza vaccine, with younger individuals being less likely to be aware (OR 0.48, 95% CI 0.29–0.77, p?<?0.05) and less likely to receive the vaccine annually (OR 0.28, 95% CI 0.19–0.42, p?<?0.05). Leading reasons respondents gave as to why they did not receive their influenza vaccine from a pharmacist included not wanting or feeling they needed to be immunized (41.6%) and being used to receiving the vaccine from a physician (16.5%). Concerns about the experience and training of pharmacists and lack of privacy in a community pharmacy were uncommon.Conclusion
Reduced awareness of the availability of pharmacist-provided influenza vaccine is still common. Pharmacists have a significant opportunity to address lack of awareness and vaccine hesitancy issues. They can promote this service to increase influenza vaccination rates among pharmacy patrons who do not utilize this professional service. 相似文献126.
127.
128.
Die Anaesthesiologie - Das Management des schwierigen Atemwegs ist eine präklinische Schlüsselqualifikation. Für Notärzte mit hohem Erfahrungsgrad im Atemwegsmanagement sind... 相似文献
129.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献130.
K. A. Harding M. E. Pushpanathan S. R. Whitworth S. Nanthakumar R. S. Bucks T. C. Skinner 《Diabetic medicine》2019,36(12):1600-1611